Supportive-Expressive and Emotion-Focused Treatment for Depression
SETEFT
Investigating Mechanisms of Change in Supportive-Expressive vs. Emotion-Focused Treatment of Depression Using a Personalized Treatment Approach: The Case of the Theories of Weakness vs. Strength
1 other identifier
interventional
124
1 country
1
Brief Summary
This study will explore the mechanisms of change that are activated when individuals receive a treatment that targets their weakness and the mechanisms activated when the treatment capitalize on their strength. Patients will be assigned to one of two types of psychotherapies in treating people with a major depression disorder, expressive-supportive vs. emotion-focused treatment. Their ability to benefit from treatment based on their pre-treatment levels of insight and emotional processing will be examined. This is a four-month protocol, with a 2 year follow up period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable major-depressive-disorder
Started Nov 2020
Longer than P75 for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2020
CompletedFirst Posted
Study publicly available on registry
October 6, 2020
CompletedStudy Start
First participant enrolled
November 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2027
May 7, 2026
May 1, 2026
6 years
September 26, 2020
May 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weekly change in Hamilton rating scale for depression (HRSD)
A 17-item clinically administered measure assessing the severity of depression. Higher scores indicate worse outcome.
up to 16 weeks.
Secondary Outcomes (4)
Weekly change in Beck Depression Inventory (BDI)
up to 16 weeks
Weekly change in Outcome Questionnaire (OQ)
up to 16 weeks
Trajectories of change in Inventory of Interpersonal Problems (IIP-32)
At intake and 6 times during the treatment (weeks 1, 2, 4, 8, 12, 16)
trajectories of change in Quality of Life Enjoyment and Satisfaction- Short Version (Q-LES-Q)
At intake and 6 times during the treatment (weeks 1, 2, 4, 8, 12, 16)
Study Arms (2)
Supportive-Expressive
EXPERIMENTALParticipants will receive supportive-expressive treatment for 16 weeks.
Emotion-Focused
EXPERIMENTALParticipants will receive Emotion-Focused treatment for 16 weeks.
Interventions
Sixteen weeks of a time-limited psychodynamic therapy adapted for depression that includes the use of expressive techniques, such as interpretation, confrontation, clarification and the use of supportive techniques, such as affirmation and empathic validation. This treatment postulates insight as its core mechanism of change.
Sixteen weeks of a brief experiential therapy for depression that combine client-centered relational elements (unconditional positive regard, congruence, and empathy) with marker-guided experiential interventions designed to facilitate and deepen emotional processing and emotion regulation.
Eligibility Criteria
You may qualify if:
- Meeting major depressive disorder diagnostic criteria using the structured clinical interviews for Diagnostic and Statistical Manual of Mental Disorders-5 and scoring more than 14 on the 17-item Hamilton rating scale for depression at two evaluations (one week apart) (Hamilton, 1967).
- If on medication, patients' dosage must be stable for at least three months prior to entering the study, and they must be willing to maintain stable dosage for the duration of treatment
- Age between 18 and 65
- Hebrew language fluency
- Provision of written informed consent.
You may not qualify if:
- Current risk of suicide or self-harm
- current substance abuse disorders
- current or past schizophrenia or psychosis, bipolar disorder, or severe eating disorder requiring medical monitoring
- history of organic mental disease
- currently in psychotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Haifalead
- Israel Science Foundationcollaborator
Study Sites (1)
University of Haifa
Haifa, Israel
Related Publications (1)
Zilcha-Mano S, Shahar B, Fisher H, Dolev-Amit T, Greenberg LS, Barber JP. Investigating patient-specific mechanisms of change in SET vs. EFT for depression: study protocol for a mechanistic randomized controlled trial. BMC Psychiatry. 2021 Jun 2;21(1):287. doi: 10.1186/s12888-021-03279-y.
PMID: 34078324DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Double Blind (participants, outcome assessor)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 26, 2020
First Posted
October 6, 2020
Study Start
November 29, 2020
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
May 31, 2027
Last Updated
May 7, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Data will not be shared due to ethical reasons.